Viekira Pak

Medically Reviewed on 6/2/2023

Brand Name: Viekira Pak

Generic Name: ombitasvir, paritaprevir, ritonavir, and dasabuvir

Drug Class: HCV NS5A Inhibitors; HCV Polymerase Inhibitors; HCV Protease Inhibitors

What is Viekira Pak, and what is it used for?

Viekira Pak is a combination of drugs used to treat patients with hepatitis C virus (HCV) genotype 1. It contains four medicines, dasabuvir, ombitasvir, paritaprevir, and ritonavir. Viekira Pak belongs to a class of drugs called direct-acting antiviral agents. Similar drugs include

Dasabuvir, ombitasvir, and paritaprevir are antivirals that work in three different ways to help stop HCV from multiplying. They block the effect of proteases which are enzymes that HCV uses for making new virus, leading to reduced numbers of HCV copies in the body. Ombitasvir blocks HCV NS5A protease while paritaprevir blocks HCV NS3/4A protease. Dasabuvir blocks a viral structure called NS5B palm polymerase which is also needed for replication of HCV. Ritonavir is not active against the HCV virus. It is used to increase blood levels of paritaprevir by inhibiting the breakdown of paritaprevir.

In clinical studies Viekira Pak, with or without ribavirin (Rebetol) HCV was cured in 95% to 100% of patients treated. Cure was defined as undetectable levels of HCV in the blood 3 months after treatment. The FDA approved Viekira Pak in December 2014.

What are the side effects of Viekira Pak?

The most common side effects of Viekira Pak when used with ribavirin include

The most common side effects of Viekira Pak when used without ribavirin include

Other side effects include


What Is Viral Hepatitis? How You Catch Hepatitis A, B, and C See Slideshow

What is the dosage for Viekira Pak?

  • Viekira Pak is supplied in monthly cartons that contain enough medicine for 28 days. Each daily dose pack contains four tablets: two 12.5/75/50 mg ombitasvir, paritaprevir, ritonavir tablets and two 250 mg dasabuvir tablets.
  • The recommended dose of Viekira Pak is two tablets containing ombitasvir, paritaprevir, ritonavir in the morning and one dasabuvir tablet in the morning and evening. Viekira Pak should be taken with meals.
  • Certain patients may also be treated with ribavirin. The dosage of ribavirin is based on weight and is usually administered twice daily with food.
  • The recommended treatment regimen and duration of treatment for each type of HCV infection is as follows:
    • Patients with HCV genotype 1a without cirrhosis may be treated with Viekira Pak plus ribavirin for 12 weeks.
    • Patients with HCV genotype 1a with cirrhosis may be treated with Viekira Pak plus ribavirin for 24 weeks. (Some patients who have had prior treatment with other drugs may be considered for a shorter treatment duration of 12 weeks.)
    • Patients with HCV genotype 1b without cirrhosis may be treated with Viekira Pak for 12 weeks.
    • Patients with HCV genotype 1b with cirrhosis may be treated with Viekira Pak plus ribavirin for 12 weeks.
  • No dosage adjustment is required in patients with mild liver impairment. Viekira Pak is not recommended for patients with moderate liver impairment and is contraindicated in patients with severe liver impairment.

Which drugs interact with Viekira Pak?

Is Viekira Pak safe to take if I'm pregnant or breastfeeding?

Viekira Pak has not been evaluated in pregnant women. Therefore, Viekira Pak should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

When Viekira Pak is administered with ribavirin, the combination regimen should not be used in pregnant women and in men who can father children. Ribavirin is known to cause birth defects and should be avoided during pregnancy.

There is an antiretroviral pregnancy registry that monitors the use of products such as Viekira Pak in HCV/HIV-1 co-infected women. Patients are advised to enroll in this program to help study and understand the safety of antiretroviral therapy during pregnancy.

It is not known whether any of the drugs contained in Viekira Pak are excreted into human milk. Due to the lack of conclusive safety data, Viekira Pak should be used cautiously in nursing mothers.

What else should I know about Viekira Pak?

What preparations of Viekira Pak are available?

Tablets: 12.5/75/50 mg ombitasvir, paritaprevir, ritonavir co-packaged with 250 mg dasabuvir tablets.

How should I keep Viekira Pak stored?

Viekira Pak should be stored at room temperature between 15 C and 30 C (59 F and 86 F). Viekira Pak as well as all medicines should be kept out of the reach of children and pets.

Subscribe to MedicineNet's General Health Newsletter

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.


Viekira Pak (ombitasvir, paritaprevir, ritonavir, and dasabuvir) is a combination drug prescribed to treat hepatitis C infection to include those patients with compensated liver cirrhosis. Side effects, drug interactions, dosing, storage, and pregnancy and breastfeeding information should be reviewed prior to taking this medication

Treatment & Diagnosis

Medications & Supplements

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Medically Reviewed on 6/2/2023
FDA Prescribing Information.